ami multistem
Cell therapyexperimental
Clinical trial activity
2 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2008 (NCT00677222)
Timeline
Indications
Mechanism of action
- Unspecified targetTissue restoration
Tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ami multistem
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02277613 | Phase 2 | Jun 1, 2015 | Athersys, Inc, National Heart, Lung, and Blood Institute (NHLBI), Summa Health System |
| NCT00677222 | Phase 1 | May 1, 2008 | Angiotech Pharmaceuticals, Athersys, Inc, Columbia University, PPD, University of Rochester |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Athersys, Inc | For profit | 2 | 2 | 2 | 2008 |
| Angiotech Pharmaceuticals | For profit | 1 | 0 | 1 | 2008 |
| Columbia University | Academic/Hospital | 1 | 0 | 1 | 2008 |
| National Heart, Lung, and Blood Institute (NHLBI) | Government | 1 | 0 | 1 | 2015 |
| PPD | For profit | 1 | 0 | 1 | 2008 |
| Summa Health System | Academic/Hospital | 1 | 0 | 1 | 2015 |
| University of Rochester | Academic/Hospital | 1 | 0 | 1 | 2008 |
7 organizations
Page 1 / 1